CME Group Inc. (CME) Price Target Increased to $116.00 by Analysts at Deutsche Bank AG
CME Group Inc. (NASDAQ:CME) had its price objective increased by Deutsche Bank AG from $115.00 to $116.00 in a research report report published on Wednesday morning. The firm currently has a buy rating on the stock.
Other analysts have also issued reports about the stock. Credit Agricole SA reduced their price target on shares of CME Group from $100.00 to $95.00 and set an underperform rating for the company in a research report on Thursday, July 14th. Keefe, Bruyette & Woods increased their price target on shares of CME Group from $99.00 to $103.00 and gave the stock a market perform rating in a research report on Friday, July 29th. Barclays PLC reduced their price target on shares of CME Group from $100.00 to $99.00 and set an equal weight rating for the company in a research report on Friday, July 29th. Zacks Investment Research raised shares of CME Group from a hold rating to a buy rating and set a $116.00 price target for the company in a research report on Thursday, August 4th. Finally, JPMorgan Chase & Co. increased their price target on shares of CME Group from $99.00 to $106.00 and gave the stock an overweight rating in a research report on Friday, July 29th. Two research analysts have rated the stock with a sell rating, six have given a hold rating and six have issued a buy rating to the company. The stock has a consensus rating of Hold and an average price target of $103.18.
Shares of CME Group (NASDAQ:CME) traded up 0.05% on Wednesday, hitting $104.11. 316,980 shares of the stock traded hands. CME Group has a 12-month low of $81.87 and a 12-month high of $110.35. The stock has a market cap of $35.28 billion, a price-to-earnings ratio of 26.29 and a beta of 0.83. The stock has a 50-day moving average price of $106.82 and a 200 day moving average price of $99.32.
CME Group (NASDAQ:CME) last posted its quarterly earnings results on Thursday, July 28th. The company reported $1.14 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.11 by $0.03. The business earned $906 million during the quarter, compared to analyst estimates of $897.84 million. CME Group had a net margin of 38.22% and a return on equity of 6.83%. The firm’s revenue was up 10.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.95 earnings per share. On average, analysts anticipate that CME Group will post $4.44 earnings per share for the current fiscal year.
The business also recently announced a quarterly dividend, which was paid on Monday, September 26th. Stockholders of record on Friday, September 9th were given a dividend of $0.60 per share. The ex-dividend date of this dividend was Wednesday, September 7th. This represents a $2.40 annualized dividend and a dividend yield of 2.31%. CME Group’s payout ratio is currently 60.61%.
In related news, insider Hilda Harris Piell sold 893 shares of the business’s stock in a transaction that occurred on Monday, September 19th. The stock was sold at an average price of $110.00, for a total value of $98,230.00. Following the completion of the transaction, the insider now directly owns 29,125 shares in the company, valued at approximately $3,203,750. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Bryan T. Durkin sold 15,000 shares of the business’s stock in a transaction that occurred on Tuesday, September 6th. The shares were sold at an average price of $107.75, for a total value of $1,616,250.00. Following the completion of the transaction, the insider now owns 63,967 shares of the company’s stock, valued at $6,892,444.25. The disclosure for this sale can be found here. Insiders own 0.61% of the company’s stock.
Institutional investors have recently modified their holdings of the stock. FMR LLC raised its position in shares of CME Group by 86.8% in the second quarter. FMR LLC now owns 6,394,597 shares of the company’s stock valued at $622,833,000 after buying an additional 2,971,686 shares in the last quarter. Investec Asset Management LTD raised its position in shares of CME Group by 5,297.7% in the first quarter. Investec Asset Management LTD now owns 1,569,814 shares of the company’s stock valued at $150,781,000 after buying an additional 1,540,731 shares in the last quarter. Westfield Capital Management Co. LP acquired a new position in shares of CME Group during the second quarter valued at about $93,330,000. Edgewood Management LLC raised its position in shares of CME Group by 20.3% in the second quarter. Edgewood Management LLC now owns 5,482,310 shares of the company’s stock valued at $533,977,000 after buying an additional 923,942 shares in the last quarter. Finally, Kleinwort Benson Investors Dublin Ltd acquired a new position in shares of CME Group during the second quarter valued at about $80,125,000. Institutional investors and hedge funds own 80.29% of the company’s stock.
About CME Group
CME Group Inc is a provider of products across all major asset classes, based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals. The Company’s products include both exchange-traded and privately negotiated futures and options contracts and swaps. The Company connects buyers and sellers together through its CME Globex electronic trading platform across the globe and its open outcry trading facilities in Chicago and New York City.
Receive News & Stock Ratings for CME Group Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group Inc. and related stocks with our FREE daily email newsletter.